GB1572309A - Creation of Inventions and Patents with Artificial Intelligence

GB1572309A – Process for the manufacture of 5-methyl isoxazole-4-carboxylic acid anilide derivatives
– Google Patents

GB1572309A – Process for the manufacture of 5-methyl isoxazole-4-carboxylic acid anilide derivatives
– Google Patents
Process for the manufacture of 5-methyl isoxazole-4-carboxylic acid anilide derivatives

Download PDF
Info

Publication number
GB1572309A

GB1572309A
GB5034277A
GB5034277A
GB1572309A
GB 1572309 A
GB1572309 A
GB 1572309A
GB 5034277 A
GB5034277 A
GB 5034277A
GB 5034277 A
GB5034277 A
GB 5034277A
GB 1572309 A
GB1572309 A
GB 1572309A
Authority
GB
United Kingdom
Prior art keywords
carboxylic acid
anilide
group
methylisoxazole
carbon atoms
Prior art date
1976-12-03
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Expired

Application number
GB5034277A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Hoechst AG

Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
1976-12-03
Filing date
1977-12-02
Publication date
1980-07-30

1977-12-02
Application filed by Hoechst AG
filed
Critical
Hoechst AG

1980-07-30
Publication of GB1572309A
publication
Critical
patent/GB1572309A/en

Status
Expired
legal-status
Critical
Current

Links

Espacenet

Global Dossier

Discuss

Classifications

C—CHEMISTRY; METALLURGY

C07—ORGANIC CHEMISTRY

C07D—HETEROCYCLIC COMPOUNDS

C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings

C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings

C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members

C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms

C07D261/18—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen

Abstract

Preparation of novel 5-methylisoxazole-4-carboxanilides of the formula I in which the individual symbols have the meaning given in Patent Claim 1, by reaction of a 5-methylisoxazole-4-carboxylic acid derivative with an appropriately substituted aniline. The compounds of the formula I are pharmacologically active. They exhibit potent anti-inflammatory and analgesic action.

Description

(54) PROCESS FOR THE MANUFACTURE OF
5-METHYL ISOXAZOLE-4-CARBOXYLIC ACID ANILIDE DERIVATIVES
(71) We. HOECHST AKTIENGESELLSCHAFT, a body corporate organised according to the laws of the Federal Republic of Germany, of 6230 Frankfurt/Main 80, Postfach 80 ()3 20. Federal Republic of Germany, do hereby declare the invention for which we pray that a patent may be granted to us, and the method by which it is to be performed, to be particularly described in and by the following statement:
This invention relates to a process for the manufacture of isoxazole derivatives and is an improvement in or modification of the invention forming the subject of specification No.
1547452. which provides a 5-methyl-isoxazole-4-carboxylic acid anilide of the general formula I
in which R’, R2 and R3, which may be identical or different, each represents an alkyl group having 1. 2 or 3 carbon atoms, an alkoxy group having 1, 2 or 3 carbon atoms, an alkylthio group having 1. 2 or 3 carbon atoms, the alkyl group of which may be completely or partially substituted by identical or different halogen atoms, for example, fluorine, chlorine, bromine and iodine atoms; or represents a halogen atom, for example, a fluorine, chlorine, bromine or iodine atom. or represents a nitro or cyano group, or an alkoxycarbonyl group having 1. 2 or 3 carbon atoms in the alkyl moiety, and in which Rl and R- may each further represent a hydrogen atom, provided that when both represent hydrogen atoms R3 cannot represent a methyl group, and when one or both of R or R2 represents hydrogen. R3 may additionally represent a phenyl or phenoxy group which may carry one or two substituents selected from fluorine, chlorine, bromine and iodine atoms, alkyl groups having 1. 2 or 3 carbon atoms and alkoxy groups having 1,2 or 3 carbon atoms, or
in which R’ denotes a hydrogen atom and R2 and R3 together represent a methylenedioxy group or, together with the phenyl ring to which they are linked, represent a naphthalene ring. and which furthermore, provides a process for the manufacture of the compound of the formula I, which comprises treating a 2-alkoxymethyleneacetoacetic acid anilide of the formula IV
in which Rl. R2 and R are as defined above and R represents an alkyl group having 1 to 4 carbon atoms with hydroxylamine in an organic solvent, an aqueous/organic solvent, or a mixture of two or more organic solvents.
The acetoacetic acid anilides of formula IV may be prepared by a process wherein an acetoacetic acid anilide of
the formula II R3 CH3″CO-CZ-CONH- (11) R2 R1 in which R, . R2 and R3 are as defined above, is heated with an orthoformic acid ester of the formula Ill HC(OR)3 (III) wherein K represents an alkyl group having I to 4 carbon atoms and preferably with an acid anhydride.
The present invention provides a process for the manufacture of a 5-methyl-isoxazole-4 carboxylic acid anilide of the general formula I, wherein an aniline of the general formula V
in which R’, R2 and R3 have the abovementioned meanings, is reacted with a compound of the formula VI
in which X denotes a halogen atom, preferably a chlorine or bromine atom, a carbodiimide group, or a YO-group or a ZO-CO-O- group, Y representing a phenyl group which may be monosubstituted. disubstituted or trisubstituted by the same or different substituents, as appropriate. selected from fluorine. chlorine, bromine, and iodine atoms, methyl, ethyl, methoxy, ethoxy. nitro and cyano groups, or denotes the acyl radical corresponding to the formula VI and Z representing an alkyl group having from 1 to 4 carbon atoms or a benzyl or phenyl group.
When a phenyl or phenoxy group R3 carries two substituents, these are preferably the same, and when Y represents a phenyl group carrying two or three substituents, these are preferably the same.
Advantageously. the reaction is carried out in a partitioning agent or solvent which has an inert behaviour towards the reactants. for example, a nitrile, for example, acetonitrile; an ether, for example. diethyl ether, tetrahydrofuran or dioxane; or an alcohol, for example, methanol, ethanol, propanol or isopropanol.
A preferred process for the preparation of the compound of the formula I is the reaction of the carboxylic acid chloride of the formula VI with an aniline of the formula V. It is advantageous in this case to carry out the reaction in the presence of an acid-binding agent, for example, potassium carbonate or sodium carbonate, an alkali metal or alkaline earth metal hydroxide or alcoholate. an organic base, for example triethylamine, pyridine, picoline or quinoline or an excess of the particular aniline employed, at a temperature of from 0 to 16()0C, preferably from 20 to 80″C. The reaction times generally range from a few minutes to two hours.
The reactive derivatives of the 5-methylisoxazole-4-carboxylic acid of the formula VI required as starting materials from the process according to the invention, may be obtained in a manner which is in itself known (compare German Patent Specification No. 634 286) by the reaction of an ethoxymethylideneacetoacetic acid ester with hydroxylamine to give a 5-methyl-isoxazole-4-carboxylic acid ester, by acid saponification of the ester thus obtained, preferably using a mixture of glacial acetic acid and concentrated hydrochloric acid in a ratio of 1:1, to give 5-methyl-isoxazole-4-carboxylic acid, and by activation of this carboxylic acid group. for example, by formation of the carboxylic acid halides, ester or anhvdrides. The 5-methylisoxazole-4-carboxylic acids can also be activated by reaction with a carbodiimide, for example dicyclohexylcarbodiimide.
Examples of the carboxylic acid derivatives of formula VIa are 5-methylisoxazole-4carboxvlic acid phenyl esters. in particular the 2,4-dichloro-phenyl ester and the 2.4.6-trichlorophenyl ester, and furthermore 5-methylisoxazole-4-carboxylic acid anhydrides. in particular those in which X denotes a methoxycarbonyloxy radical, an ethoxycarbonyloxy radical or a benzyloxycarbonyloxy radical.
5 10 15 20 25 30 35 40 45 50 55 60 65
The compounds of the formula I are pharmacologically active, having a strong antiphlogistic and analgesic action.
The invention also provides a pharmaceutical preparation which comprises a compound of the general formula I which itself forms part of this invention in admixture or conjunction with a pharmaceutically suitable carrier.
The following Examples illustrate the invention.
Example S-methylisoxazole-4-carboxylic acid 4-fluoro-anilide
a,) A solution of 7.3 g (0.05 mole) of 5-methylisoxazole-4-carboxylic acid chloride of the formula VI in 20 ml of acetonitrile is added dropwise, whilst stirring, at room temperature to ().l mole of 4-fluoroaniline of the formula V (11.1 g), dissolved in 200 ml of acetonitrile. After stirring for a further 15 minutes, the crystals which have precipitated are filtered off and rinsed with twice 2() ml of acetonitrile and the combined filtrates are brought to dryness under reduced pressure. This gives 10.8 g (98% of theory) of an oily residue which crystallizes after trituration.
Melting point after recrystallisation from water: 117 to 118″C.
a2) When 0.05 mole of triethylamine (10.1 g) is used as the acid-binding agent instead of the 4-fluoroaniline of the formula V the oily residue is digested with water. The crystals thus obtained are filtered off and washed with water. After drying in air, this gives 10.6 g (96% of theory) of colorless crystals which, after recrystallization from water, melt at 117 to 118″C.
b) 0.1 mole of 4-fluoroaniline of the formula V (11.1 g) and 0.1 mole of 4-bromophenyl 5-methylisoxazole-4-carboxylate of the formula VI (28.2 g) dissolved in 50 ml of acetonitrile are heated under reflux for 90 minutes. Subsequently the solution is evaporated under reduced pressure and the residue is digested with petroleum ether. This gives 15.6 g (71% of theory) of an oily residue which crystallizes after spreading out. Melting point after recrystallization from water: 117 to 118″C.
c) 0.1 mole of 4-fluoroaniline of the formula V (11.1 g) and 0.1 mole of ethoxycarbonyl 5-methylisoxazole-4-carboxylate of the formula VI (19.9 g), dissolved in 60 ml of tetrahydrofurane. are heated under reflux for 60 minutes. The reaction mixture is then brought to dryness and this gives 17.1 g (786/c of theory) of a crystalline residue which, after recrystallization from water melts at 117 to 118″C.
The compounds listed in Table 1 were prepared by the process indicated above.
TABLE 1: 5-methylisoxazoíe-4-carboxylic acid anilides of the formula I
No R’ R2 R3 Melting point C
H H 4l 117 – 118 2 H II 4-(1 151 3 H ll 4-Br 162 – 163 4 H ll 4-1 173 – 173.5 5 H 3 (‘l 4-Cl 146 6 H 3 (‘l 4-F 123 – 124
-O 7 H 3.4 CH2 125 – 126
-O 8 H 3 F 4-F l(n – 1()9 9 H 3 F 4-Cl 1()5 1()7 10 H ‘-F 4-F 123 11 H 2 -F 5-CF3 1()7 – l()X The numbers in Table 1 denote:
1. 5-Methylisoxazole-4-carboxylic acid 4-fluoro-anilide
2. 5-Methylisoxazole-4-carboxylic acid 4-chloro-anilide
3. 5-Methylisoxazole-4-carboxylic acid 4-bromo-anilide
4. 5-Methylisoxazole-4-carboxylic acid 4-iodo-anilide 5-Methylisoxazole-4-carboxylic acid 3,4-dichloro-anilide 6. 5-Methylisoxazole-4-carboxvlic acid 3-chloro-4-fluoro-anilide
7. 5-Methvlisoxazole-4-carboxylic acid 3.4-methylenedioxy-anilide
8. 5-Methylisoxazole-4-carboxylic acid 3,4-difluoro-anilide
9. 5-Methylisoxazole-4-carboxylic acid 4-chloro-3-fluoro-anilide 10. 5-Methylisoxazole-4-carboxylic acid 2,4-difluoro-anilide 11. 5-Methylisoxazole-4-carboxylic acid 2-fluoro-5-trifluoromethyl anilide
WHAT WE CLAIM IS:
1. A process for the manufacture of a 5-methyl-isoxazole-4-carboxylic acid anilide of the general formula I

in which R’. R2 and R3. which may be identical or different, each represents an alkyl group having 1. 2 or 3 carbon atoms, an alkoxy group having 1, 2 or 3 carbon atoms, an alkylthio group having 1, 2 or 3 carbon atoms, the alkyl group of which may be completely or partially substituted by identical or different halogen atoms; or represents a halogen atom. or represents a nitro or cyano group. or an alkoxycarbonyl group having 1, 2 or 3 carbon atoms in the alkyl moiety. and in which R’ and R2 may each further represent a hydrogen atom. provided that when both represent hydrogen atoms R3 cannot represent a methyl group, and when one or both of R’ and R2 represents hydrogen, R3 may additionally represent a phenyl or phenoxy group which may carry one or two substituents selected from fluorine. chlorine, bromine and iodine atoms, alkyl groups having 1, 2 or 3 carbon atoms and alkoxy groups having 1. 2 or 3 carbon atoms, or
in which R’ denotes a hydrogen atom and R2 and R3 together represent a methvlenedioxv group or, together with the phenyl ring to which they are linked, represent a naphthalene ring, wherein an aniline of the formula V

**WARNING** end of DESC field may overlap start of CLMS **.

Claims (1)

**WARNING** start of CLMS field may overlap end of DESC **.
TABLE 1: 5-methylisoxazoíe-4-carboxylic acid anilides of the formula I
No R’ R2 R3 Melting point C
H H 4l 117 – 118 2 H II 4-(1 151 3 H ll 4-Br 162 – 163 4 H ll 4-1 173 – 173.5 5 H 3 (‘l 4-Cl 146 6 H 3 (‘l 4-F 123 – 124
-O 7 H 3.4 CH2 125 – 126
-O 8 H 3 F 4-F l(n – 1()9 9 H 3 F 4-Cl 1()5 1()7 10 H ‘-F 4-F 123 11 H 2 -F 5-CF3 1()7 – l()X The numbers in Table 1 denote:
1. 5-Methylisoxazole-4-carboxylic acid 4-fluoro-anilide
2. 5-Methylisoxazole-4-carboxylic acid 4-chloro-anilide
3. 5-Methylisoxazole-4-carboxylic acid 4-bromo-anilide
4. 5-Methylisoxazole-4-carboxylic acid 4-iodo-anilide 5-Methylisoxazole-4-carboxylic acid 3,4-dichloro-anilide
6. 5-Methylisoxazole-4-carboxvlic acid 3-chloro-4-fluoro-anilide
7. 5-Methvlisoxazole-4-carboxylic acid 3.4-methylenedioxy-anilide
8. 5-Methylisoxazole-4-carboxylic acid 3,4-difluoro-anilide
9. 5-Methylisoxazole-4-carboxylic acid 4-chloro-3-fluoro-anilide 10. 5-Methylisoxazole-4-carboxylic acid 2,4-difluoro-anilide 11. 5-Methylisoxazole-4-carboxylic acid 2-fluoro-5-trifluoromethyl anilide
WHAT WE CLAIM IS:
1. A process for the manufacture of a 5-methyl-isoxazole-4-carboxylic acid anilide of the general formula I

in which Rl, R2 and R3 have the above meanings, is reacted with a compound of the formula VI
in which X denotes a halogen atom, a carbodiimide group, or a YO- group or ZO-CO-Ogroup, Y representing a phenyl group which may be monosubstituted, disubstituted or trisubstituted by the same or different substituents, as appropriate, selected from fluorine, chlorine, bromine, and iodine atoms, and methyl, ethyl, methoxy, ethoxy, nitro and cyano groups, or represents the acyl radical corresponding to the formua VI, and Z represents an alkyl group having from 1 to 4 carbon atoms, or a benzyl or phenyl group.
2. A process as claimed in claim 1, wherein X represents a chlorine atom and the reaction is carried out at a temperature of from 0 to 1600C in the presence of an acid binding agent.
3. A process as claimed in claim 1, wherein X represents a phenoxy, 2,4dichlorophenoxy, 2,4,6-trichlorophenoxy, methoxycarbonyloxy, ethoxycarbonyloxy or benzyloxycarbonyloxy group.
4. A process as claimed in claim 1, carried out substantially as described in Example a,, a2, b or c herein.
5. A compound of the general formula I as defined in claim 1, whenever produced by a process as claimed in any one of claims 1 to 4.
6. A compound as described in Table 1, whenever produced by a process as claimed in claim 1.
7. A pharmaceutical preparation which comprises a compound as claimed in claim 5 or claim 6 in admixture or conjunction with a pharmaceutically suitable carrier.

GB5034277A
1976-12-03
1977-12-02
Process for the manufacture of 5-methyl isoxazole-4-carboxylic acid anilide derivatives

Expired

GB1572309A
(en)

Applications Claiming Priority (1)

Application Number
Priority Date
Filing Date
Title

DE19762654797

DE2654797A1
(en)

1976-12-03
1976-12-03

PROCESS FOR THE PREPARATION OF ISOXAZOLE DERIVATIVES

Publications (1)

Publication Number
Publication Date

GB1572309A
true

GB1572309A
(en)

1980-07-30

Family
ID=5994582
Family Applications (1)

Application Number
Title
Priority Date
Filing Date

GB5034277A
Expired

GB1572309A
(en)

1976-12-03
1977-12-02
Process for the manufacture of 5-methyl isoxazole-4-carboxylic acid anilide derivatives

Country Status (14)

Country
Link

JP
(1)

JPS5371068A
(en)

AT
(1)

AT361917B
(en)

BE
(1)

BE861500R
(en)

CA
(1)

CA1095056A
(en)

CH
(1)

CH609341A5
(en)

DE
(1)

DE2654797A1
(en)

DK
(1)

DK538777A
(en)

ES
(1)

ES464533A2
(en)

FR
(1)

FR2381756A2
(en)

GB
(1)

GB1572309A
(en)

IE
(1)

IE46001B1
(en)

IT
(1)

IT1089430B
(en)

LU
(1)

LU78614A1
(en)

NL
(1)

NL7713083A
(en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party

Publication number
Priority date
Publication date
Assignee
Title

EP0035285A3
(en)

1979-08-17
1981-10-14
American Cyanamid Company
Novel isoxazole carboxylic acid phenyl esters, pharmaceutical compositions containing certain of said esters, and process for preparing said esters

JPS55500866A
(en)

1978-11-03
1980-10-30

DE2854439A1
(en)

1978-12-16
1980-07-03
Hoechst Ag

AN ISOXAZOLE DERIVATIVE, METHOD FOR THE PRODUCTION THEREOF, AGENT AND USE THEREOF

DE2854438A1
(en)

1978-12-16
1980-07-03
Hoechst Ag

ISOXAZOLE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, MEANS CONTAINING THESE COMPOUNDS AND THEIR USE

FI71129C
(en)

1979-06-11
1986-11-24
Ciba Geigy Ag

FOERFARANDE FOER FRAMSTAELLNING AV FARMACEUTISKT AKTIVA ALFAKARBAMOYLPYRROLPROPIONITRILER

DE3247454A1
(en)

1982-12-22
1984-06-28
Laboratorios Bago S.A., Buenos Aires
Substituted 3-phenyl-5-methylisoxazole-4-carboxanilides, process for their preparation and pharmaceutical compositions containing these compounds

GB8619432D0
(en)

1986-08-08
1986-09-17
Lilly Industries Ltd
Pharmaceutical compounds

Family Cites Families (2)

* Cited by examiner, † Cited by third party

Publication number
Priority date
Publication date
Assignee
Title

NL178596C
(en)

1975-06-05
1986-04-16
Hoechst Ag

METHOD FOR PREPARING A MEDICINAL PRODUCT WITH ANTIFLOGISTIC AND / OR ANALGETIC ACTION, AND A METHOD FOR PREPARING THEIR PRODUCT TO BE USED AS MEDICINAL COMPOUNDS 5-METHYLISOXAZOLE-4-CARBONIC ACID.

DE2525023A1
(en)

1975-06-05
1976-12-16
Hoechst Ag
N-Halophenyl isoxazole-4-carboxamides – are fungicides useful in plant protection

1976

1976-12-03
DE
DE19762654797
patent/DE2654797A1/en
not_active
Withdrawn

1977

1977-11-15
CH
CH1393277A
patent/CH609341A5/en
not_active
IP Right Cessation

1977-11-28
NL
NL7713083A
patent/NL7713083A/en
not_active
Application Discontinuation

1977-11-28
ES
ES464533A
patent/ES464533A2/en
not_active
Expired

1977-12-01
LU
LU78614A
patent/LU78614A1/xx
unknown

1977-12-01
IT
IT3028677A
patent/IT1089430B/en
active

1977-12-02
DK
DK538777A
patent/DK538777A/en
not_active
Application Discontinuation

1977-12-02
FR
FR7736424A
patent/FR2381756A2/en
active
Granted

1977-12-02
CA
CA292,253A
patent/CA1095056A/en
not_active
Expired

1977-12-02
AT
AT866177A
patent/AT361917B/en
not_active
IP Right Cessation

1977-12-02
GB
GB5034277A
patent/GB1572309A/en
not_active
Expired

1977-12-02
IE
IE245377A
patent/IE46001B1/en
unknown

1977-12-03
JP
JP14561977A
patent/JPS5371068A/en
active
Pending

1977-12-05
BE
BE183167A
patent/BE861500R/en
not_active
IP Right Cessation

Also Published As

Publication number
Publication date

NL7713083A
(en)

1978-06-06

LU78614A1
(en)

1978-07-14

ES464533A2
(en)

1979-10-16

AT361917B
(en)

1981-04-10

DK538777A
(en)

1978-06-04

CH609341A5
(en)

1979-02-28

IE46001L
(en)

1978-06-03

IE46001B1
(en)

1983-01-26

IT1089430B
(en)

1985-06-18

CA1095056A
(en)

1981-02-03

JPS5371068A
(en)

1978-06-24

BE861500R
(en)

1978-06-05

ATA866177A
(en)

1980-09-15

FR2381756B2
(en)

1982-10-29

FR2381756A2
(en)

1978-09-22

DE2654797A1
(en)

1978-06-08

Contact information